logo-loader

Redx Pharma 'on a firm footing and able to drive its business plan' following new $30mln facility

Published: 22:56 30 Jun 2020 AEST

Redx Pharma PLC's (LON:REDX) Lisa Anson caught up with Proactive London's Andrew Scott after announcing they've raised US$30mln via the issue of convertible loan notes.

Funds Redmile Group and Sofinnova Partners are putting up US$19mln and US$10mln respectively.

The cash will be used to repay US$6.1mln of short-term debt as well as advancing the development of its oncology and fibrosis drugs.

New Redx CEO bringing leadership and skills to 'capitalise on its great science'

Lisa Anson, the new chief executive at Redx Pharma Plc (LON:REDX), sat down with Proactive's Andrew Scott just weeks after taking on the new role. Anson was the president of AstraZeneca PLC’s (LON:AZN) UK division immediately prior to joining, while she's also held various other senior...

on 19/7/18